Latest Breaking News On - Werewolf therapeutics - Page 5 : comparemela.com

Werewolf Therapeutics (HOWL) Provides Business Update and Highlights 2024 Strategic Outlook

Werewolf Therapeutics Stock: Still In The Race To Develop Next Generation Cytokines (HOWL)

Cytovation Announces Appointment of Ellen Lubman, MBA to its Board of Directors

Bergen, Norway, December 20, 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targ.

Werewolf Therapeutics (NASDAQ:HOWL) Stock Price Down 2.2%

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) was down 2.2% on Tuesday . The company traded as low as $2.48 and last traded at $2.62. Approximately 102,646 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 337,653 shares. The stock had previously closed at $2.68. Wall Street […]

Institutions profited after Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) market cap rose US$14m last week but private equity firms profited the most

Key Insights Werewolf Therapeutics' significant private equity firms ownership suggests that the key decisions are.